Skip to content
  • My Cerba Research
  • Labphone
  • Careers
  • Contact
  • Visit Our Virtual Venue
  • Our DNA
    • Our DNA
    • Our Mission
    • Partnership
    • Global Footprint
    • Leadership Team
    • Corporate Social Responsibility
  • Lab Solutions
    • Central Lab
      • Biobanking and Storage
      • Custom Assay Development
      • Routine Testing
      • Global Project Management
      • Operational Support
      • Artificial Intelligence
    • Biomarkers
    • Companion Diagnostics
    • In Vitro Diagnostics
    • Quality Assurance
      • Regulatory Compliance
  • Test Menu
    • Methodology
      • Flow Cytometry
      • Histopathology and Immunohistochemistry
      • Genetics
    • Therapeutic Areas
      • Oncology
      • Metabolic Diseases
      • Infectious Diseases
        • COVID-19 Resource Center
      • Inflammatory and Autoimmune Diseases
      • Neurology
      • Rare Diseases
  • News & Insights
    • News
    • Blog
    • Events
    • Library
Cerba COVID-19 News

Cerba COVID-19 News

CEO Message

Home // Cerba COVID-19 News

Press Release

COVID-19: Laboratoire Cerba Ready to Sequence on a Larger Scale

June 22, 2021

Press Release

COVID-19: Institut Imagine and Cerba HealthCare are partnering to test for patients likely to develop severe symptoms

March 24, 2021

Press Release

Cerba Research Announces Time-Saving COVID-19 Exploratory Tools and NGS Advancements

January 20, 2021

COVID-19 Update

Cerba Xpert plays essential role in the French response to COVID-19

November 6, 2020

COVID-19 Update

Covid-19 samples available through Cerba Research IVD Division

April 9, 2020

COVID-19 Update

Cerba Research Proud to be part of Government Task Force in combat against Covid-19

April 8, 2020

COVID-19 Update

Covid-19 testing at Cerba Research’s partner labs

March 20, 2020

COVID-19 Update

Partner, Teddy Lab, selected as central lab for Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

March 19, 2020

COVID-19 Update

Business Continuity Plan – Coronavirus (COVID-19)

March 17, 2020

COVID-19 Update

Communication on Coronavirus (COVID-19)

March 10, 2020

Cerba Research’s COVID-19 Response Resources:

CEO Message

A message from Cerba Research’s CEO Mario Papillon

Business Continuity

Cerba Research is committed to ensuring the well-being of our employees, our customers, investigator sites, and patients.

Service Offerings

Explore Cerba Research’s COVID-19 services and tests.

Together, we’ll change the shape of your clinical development.

As your partner, Cerba Research empowers you to bring new, life-changing therapies to patients worldwide.

Start With Cerba

© 2022 Cerba Research. All Rights Reserved.

  • Privacy
  • Contact
  • Our DNA
    • Our DNA
    • Our Mission
    • Partnership
    • Global Footprint
    • Leadership Team
    • Corporate Social Responsibility
  • Lab Solutions
    • Central Lab
      • Biobanking and Storage
      • Custom Assay Development
      • Routine Testing
      • Global Project Management
      • Operational Support
      • Artificial Intelligence
    • Biomarkers
    • Companion Diagnostics
    • In Vitro Diagnostics
    • Quality Assurance
      • Regulatory Compliance
  • Test Menu
    • Methodology
      • Flow Cytometry
      • Histopathology and Immunohistochemistry
      • Genetics
    • Therapeutic Areas
      • Oncology
      • Metabolic Diseases
      • Infectious Diseases
        • COVID-19 Resource Center
      • Inflammatory and Autoimmune Diseases
      • Neurology
      • Rare Diseases
  • News & Insights
    • News
    • Blog
    • Events
    • Library
  • My Cerba Research
  • Labphone
  • Careers
  • Contact
  • Visit Our Virtual Venue
Did you find what you were looking for?
What were you looking for?
Do you want to speak to a sales representative?
Contact Us